NO961949D0 - Interdigitasjons-fusjonsliposomer inneholdende arachidonsyre metabolitter - Google Patents

Interdigitasjons-fusjonsliposomer inneholdende arachidonsyre metabolitter

Info

Publication number
NO961949D0
NO961949D0 NO961949A NO961949A NO961949D0 NO 961949 D0 NO961949 D0 NO 961949D0 NO 961949 A NO961949 A NO 961949A NO 961949 A NO961949 A NO 961949A NO 961949 D0 NO961949 D0 NO 961949D0
Authority
NO
Norway
Prior art keywords
arachidonic acid
acid metabolites
liposomes containing
interdigitation
containing arachidonic
Prior art date
Application number
NO961949A
Other languages
English (en)
Other versions
NO312808B1 (no
NO961949L (no
Inventor
Andrew Stuart Janoff
Sharma R Minchey
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO961949D0 publication Critical patent/NO961949D0/no
Publication of NO961949L publication Critical patent/NO961949L/no
Publication of NO312808B1 publication Critical patent/NO312808B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
NO19961949A 1993-11-16 1996-05-13 Interdigitasjons-fusjonsliposomer inneholdende arachidonsyremetabolitter, farmasöytisk preparat som inneholderdet samme samt fremgangsmåte for fremstilling av et medikament NO312808B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15317693A 1993-11-16 1993-11-16
PCT/US1994/013063 WO1995013797A1 (en) 1993-11-16 1994-11-15 Interdigitation-fusion liposomes containing arachidonic acid metabolites

Publications (3)

Publication Number Publication Date
NO961949D0 true NO961949D0 (no) 1996-05-13
NO961949L NO961949L (no) 1996-05-13
NO312808B1 NO312808B1 (no) 2002-07-08

Family

ID=22546097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961949A NO312808B1 (no) 1993-11-16 1996-05-13 Interdigitasjons-fusjonsliposomer inneholdende arachidonsyremetabolitter, farmasöytisk preparat som inneholderdet samme samt fremgangsmåte for fremstilling av et medikament

Country Status (13)

Country Link
EP (1) EP0729352B1 (no)
JP (1) JP3798016B2 (no)
KR (1) KR960705546A (no)
AT (1) ATE176397T1 (no)
AU (1) AU681469B2 (no)
CA (1) CA2175350A1 (no)
DE (1) DE69416425T2 (no)
DK (1) DK0729352T3 (no)
ES (1) ES2126868T3 (no)
FI (1) FI962080A (no)
GR (1) GR3030123T3 (no)
NO (1) NO312808B1 (no)
WO (1) WO1995013797A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10507737A (ja) * 1994-01-11 1998-07-28 ザ リポソーム カンパニー、インコーポレーテッド アラキドン酸代謝産物および粒子製剤を用いる治療
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
AU652552B2 (en) * 1990-01-12 1994-09-01 Liposome Company, Inc., The Interdigitation-fusion liposomes and gels
DE69228332T2 (de) * 1991-05-07 1999-09-16 The Liposome Co.,Inc. Liposomale Prostaglandinformulierungen
JPH05139977A (ja) * 1991-05-17 1993-06-08 Green Cross Corp:The プロスタグランジン類リポソーム複合体を充填した注射器

Also Published As

Publication number Publication date
GR3030123T3 (en) 1999-07-30
NO312808B1 (no) 2002-07-08
FI962080A0 (fi) 1996-05-15
WO1995013797A1 (en) 1995-05-26
DE69416425D1 (de) 1999-03-18
CA2175350A1 (en) 1995-05-26
DK0729352T3 (da) 1999-09-20
JP3798016B2 (ja) 2006-07-19
ATE176397T1 (de) 1999-02-15
KR960705546A (ko) 1996-11-08
AU1055595A (en) 1995-06-06
DE69416425T2 (de) 1999-06-10
AU681469B2 (en) 1997-08-28
ES2126868T3 (es) 1999-04-01
JPH09505302A (ja) 1997-05-27
FI962080A (fi) 1996-05-15
EP0729352B1 (en) 1999-02-03
EP0729352A1 (en) 1996-09-04
NO961949L (no) 1996-05-13

Similar Documents

Publication Publication Date Title
DK0726764T3 (da) Multilamel-liposomale arachidonsyremetabolitformuleringer
HN1997000091A (es) Estacion de cebo para termitas.
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
TR199700872A3 (tr) Kompleks lipid' lerin kullanilmasi.
DE69633293D1 (de) Für das Auge unschädliche Übertragung gefährlicher Laserstrahlen
CA2203310A1 (fr) Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale
ES2174293T3 (es) Microesferas farmaceuticas de acido valproico para la administracion oral.
DE69416425D1 (de) Arachidonsäuremetaboliten enthaltende interdigitations-fusions-liposomen
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
DE69524531D1 (de) Rücklaufsperre für Angelrolle
IT8222566A0 (it) Derivato dell'acido ursolico farmacologicamente attivo.
IT8323951A0 (it) Procedimento per la sintesi di acido ursodesossicolico coniugato con la taurina.
FR2547502B1 (fr) Matrice pour la diffusion continue et progressive d'un principe actif par voie transcutanee
IT1265422B1 (it) Unguento farmaceutico privo di azione irritativa della pelle e procedimento per la sua preparazione
ES2105973B1 (es) Composicion liposomal para la regeneracion celular de la piel.
ES1037555Y (es) Expositor autonomo para la venta combinada de laminas y de marcos.
ITBO950563A0 (it) Sistema per la sostituzione di accumulatori elettrici.
NO884448D0 (no) Ny boelgelederutforming for aa forbedre boelgelederlaserydelse.
GEU1998372Y (en) Medicinal Ointment “Tsimeriali” for Paradontitis
ES1030257Y (es) Dispositivo para la emision de mensajes publicitarios perfecionado.
ES289592Y (es) Membrana plana para altavoces

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees